Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first quarter ended September 30, 2014.
The company’s first-quarter revenues increased 39 percent to $41.4 million, from $29.8 million in the first quarter of fiscal 2014. Coronary revenues grew to $5.0 million. Customer reorder revenues remained strong at 97 percent of total revenue, compared to 96 percent in the first quarter of fiscal 2014.
Help employers find you! Check out all the jobs and post your resume.
